IN8BIO INC

Historical 13F Holders

Symbol
INAB
CUSIP
45674E208
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 45674E208 since 12/18/2024, newest first.

Filer % of Class Filed
Lytton Laurence W 13G/A Amendment 1
10.0% 8/13/2026
Event 6/30/2026
Emily Fairbairn 13D/A Amendment 1
2.2% 5/29/2026
Event 5/27/2026
Lytton Laurence W 13G
10.0% 3/2/2026
Event 12/22/2025
Alyeska Investment Group, L.P. 13G
9.9% 2/17/2026
Event 12/31/2025
Franklin Resources, Inc. 13G
9.4% 1/29/2026
Event 12/31/2025
Emily Fairbairn 13D
7.5% 1/2/2026
Event 12/22/2025
683 Capital Management, LLC 13G
7.9% 12/30/2025
Event 12/22/2025
Stonepine Capital Management, LLC 13G
9.9% 12/22/2025
Event 12/19/2025
Transcend Partners Opportunity Fund I LLC 13G/A Amendment 2 2.6% 8/13/2025
Event 6/30/2025
William Tai-Wei Ho 13G/A Amendment 3 3.7% 8/13/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 21 3.79 M $5.35 M
2026 Q1 19 3.75 M $5.55 M
2025 Q4 22 3.23 M $7.45 M
2025 Q3 18 694 k $1.51 M
2025 Q2 12 589 k $1.23 M